Sofinnova Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,002,348
| Closed | -$23.2M | – | 60 |
|
|
2023
Q1 | $23.2M | Buy |
1,002,348
+195,889
| +24% | +$4.53M | 1.48% | 18 |
|
|
2022
Q4 | $21.1M | Buy |
806,459
+518,558
| +180% | +$13.6M | 1.25% | 19 |
|
|
2022
Q3 | $5.66M | Buy |
287,901
+11,292
| +4% | +$222K | 0.33% | 37 |
|
|
2022
Q2 | $4.84M | Buy |
+276,609
| New | +$4.84M | 0.4% | 39 |
|
|
2018
Q4 | – | Sell |
-37,916
| Closed | -$1.39M | – | 70 |
|
|
2018
Q3 | $1.39M | Sell |
37,916
-10,348
| -21% | -$380K | 0.12% | 55 |
|
|
2018
Q2 | $1.69M | Buy |
48,264
+44,925
| +1,345% | +$1.57M | 0.19% | 50 |
|
|
2018
Q1 | $155K | Buy |
+3,339
| New | +$155K | 0.03% | 48 |
|